Integrated Network Analysis of Symptom Clusters Across Monkeypox Epidemics From 1970 to 2023: Systematic Review and Meta-Analysis (Preprint)
Preprint
- 25 May 2023
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND The worldwide spread of monkeypox (mpox) has witnessed a significant increase, particularly in nonendemic countries. OBJECTIVE We aimed to investigate the changing clinical symptoms associated with mpox from 1970 to 2023 and explore their interrelations. METHODS In this systematic review and meta-analysis, 3 electronic databases were searched for English peer-reviewed studies conducted from January 1970 to April 2023 that reported any symptoms among confirmed mpox cases. We categorized the mpox epidemics into 3 periods: 1970-2002 (period 1, within the African region), 2003-2021(period 2, epidemics outside Africa), and 2022-2023 (period 3, worldwide outbreak). Following PRISMA guidelines, a meta-analysis was performed to estimate the pooled prevalence for each symptom. The correlation among symptoms was analyzed and visualized using network analysis. RESULTS The meta-analysis included 61 studies that reported 21 symptoms in 720 patients from period 1, 39 symptoms in 1756 patients from period 2, and 37 symptoms in 12,277 patients from period 3. The most common symptom among patients from all 3 periods was rash (period 1: 92.6%, 95% CI 78.2%-100%; period 2: 100%, 95% CI 99.9%-100%; and period 3: 94.8%, 95% CI 90.9%-98.8%), followed by lymphadenopathy (period 1: 59.8%, 95% CI 50.3%-69.2%; period 2: 74.1%, 95% CI 64.2%-84.1%; and period 3: 61.1%, 95% CI 54.2%-68.1%). Fever (99%, 95% CI 97%-100%), enlarged lymph nodes (80.5%, 95% CI 75.4%-85.0%), and headache (69.1%, 95% CI 4%-100%) were the main symptoms in period 1, with a significant decrease in period 3: 37.9%, 31.2%, and 28.7%, respectively. Chills/rigors (73.3%, 95% CI 60.9%-85.7%), fatigue (68.2%, 95% CI 51.6%-84.8%), and dysphagia/swallowing difficulty (61.2%, 95% CI 10.5%-100%) emerged as primary new symptoms in period 2 and decreased significantly in period 3. Most other symptoms remained unchanged or decreased in period 3 compared to the former 2 periods. Nausea/vomiting had the highest degree of correlation (with 13 symptoms) and was highly positively correlated with lymphadenopathy (r=0.908) and conjunctivitis (r=0.900) in period 2. In contrast, rash and headache were 2 symptoms with the highest degree of correlation (with 21 and 21 symptoms, respectively) in period 3 and were highly positively correlated with fever (r=0.918 and 0.789, respectively). CONCLUSIONS The manifestation of symptoms in patients with mpox has become more diverse, leading to an increase in their correlation. Although the prevalence of rash remains steady, other symptoms have decreased. It is necessary to surveil the evolving nature of mpox and the consequential changes in clinical characteristics. Epidemic countries may shift their focus on the potential association among symptoms and the high synergy risk. CLINICALTRIAL PROSPERO Registration: CRD42023403282; http://tinyurl.com/yruuas5nKeywords
All Related Versions
- Published version: JMIR Public Health and Surveillance, 10 (1), e49285.
This publication has 28 references indexed in Scilit:
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statementMetaArXiv, 2020
- Clinical Course and Outcome of Human Monkeypox in NigeriaClinical Infectious Diseases, 2020
- A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategyPLOS Neglected Tropical Diseases, 2019
- Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in HumansFrontiers in Public Health, 2018
- Human Monkeypox: Current State of Knowledge and Implications for the FutureTropical Medicine and Infectious Disease, 2016
- Treasure Island2014
- Reemergence of Monkeypox: Prevalence, Diagnostics, and CountermeasuresClinical Infectious Diseases, 2005
- A tale of two clades: monkeypox virusesJournal of General Virology, 2005
- Human monkeypox: an emerging zoonosisThe Lancet Infectious Diseases, 2004
- Outbreaks of Disease Suspected of Being Due to Human Monkeypox Virus Infection in the Democratic Republic of Congo in 2001Journal of Clinical Microbiology, 2002